|
The Whole World is Watching:
MAPS Email Newsletter
|
|
December 7, 2012
|
|
|
|||||||||||||||||||||||||||
| Dear MAPS Members and Friends, It’s been a busy month for psychedelic and medical marijuana research. Most of it is captured in the headlines below—scroll down to see the impressive list of headlines generated by last month’s publication of the results of our landmark long-term follow-up study of MDMA-assisted psychotherapy for PTSD. From The New York Times and CNN to NBC and Military.com, psychedelic research is in the spotlight. The whole world is watching, and we have a responsibility and a commitment to see our work through.
In a message to our supporters sent by MAPS Executive Director Rick Doblin, Ph.D., last week, we incorrectly stated that Nature had referred to our results as “incredible.” The popular science magazine actually referred to our results as “spectacular” rather than incredible. We apologize for any confusion that might have caused. Our petition calling on U.S. military officials to support our research into MDMA-assisted psychotherapy for veterans with PTSD already has more than 1,500 signatures. Help us give veterans hope—tell the Pentagon to support our work. Here are just a few highlights from what else is new:
Early Bird rates for Psychedelic Science 2013 are only available until December 21. Time is running out to save $75 or more on conference registration—you’re not going to want to miss this extraordinary five-day event. Do you have research of your own that you’d like to present? The submission deadline for papers and posters is January 4—download our Call for Papers for details. Don’t forget to subscribe to our updates on Facebook, Twitter, and Google+, and visit our YouTube channel for videos about everything from LSD and medical marijuana to psychedelic harm reduction. There really is something for everyone. The astonishing (or is it spectacular?) transformations we are seeing in science, medicine, the popular press, and our world at large are the direct result of—you guessed it—your support. Will you help us keep up the momentum by making a gift today?
|
|||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||
|
TREATING PTSD WITH MDMA-ASSISTED PSYCHOTHERAPY Learn more about treating PTSD with MDMA-assisted psychotherapy on
|
 |
 |
 |
 |
 |
Learn how to become a Psychedelic Science 2013 Promotional Partner! |
EVENTS
9. PSYCHEDELIC SCIENCE 2013: April 18-23, 2013, Oakland, CA
Early Bird Discount Ends December 21!
Early Bird rates for Psychedelic Science 2013 end on December 21, 2012. Save $75 or more and demonstrate your belief in the future—of psychedelic medicine. The three-day conference (April 19-21) features talks ranging from psilocybin’s effect on mystical experiences (Roland Griffiths, Ph.D.), to how findings from psychedelic psychotherapy research have helped transform psychology (Dr. Stanislav Grof) and much more. Speakers from South America, North America, and Europe will present the latest research on psilocybin for cancer patients with anxiety; ayahuasca and ibogaine as treatments for nicotine and opiate addiction; MDMA-assisted psychotherapy for PTSD; psychedelic neuroscience; and much more. A wide range of anthropological and social scientific research will include reports from the field (Earth and Fire Erowid), ethical considerations related to the medicinal use of psychedelics (Dr. Julie Holland), and a review of ayahuasca customs and uses (Dennis McKenna, Ph.D.). Plus: Nine full-day pre- and post- conference Workshops (April 18 & 21), a Holotropic Breathwork Workshop with Dr. Stanislav Grof (April 21-23), a Sunset Cruise (April 19), a Dinner & Performance (April 20), and the Marketplace & Moonlight Plaza (entire conference).
Don’t wait to make sure the world will still be spinning on December 22—register today!
See our Events Calendar for more!
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
MEDIA
10. The New York Times: A “Party Drug” May Help the Brain Cope With Trauma | view
by Benedict Carey / November 19, 2012
11. CNN: Experimental Treatment for PTSD: Ecstasy | view
by Caleb Hellerman / December 1, 2012
12. VIDEO: CNN: Dr. Sanjay Gupta: Ecstasy as PTSD Treatment? | view
By Dr. Sanjay Gupta / November 30, 2012
13. Military.com: PTSD Study Findings Reinforce Case for Ecstasy | view
by Bryant Jordan / November 20, 2012
14. Reuters: Researchers Say Form of Ecstasy May Heal Combat Trauma | view
by Harriet McLeod / December 5, 2012
15. Alternet: Research Points to Clear Benefits of MDMA for Post-Traumatic Stress Disorder | view
by Craig Comstock / November 21, 2012
16. Stars and Stripes: Ecstasy Effective in Treatment of Lingering PTSD, New Study Finds | view
by Matthew M. Burke / November 20, 2012
17. Nature: MDMA Keeps Severe Stress at Bay | view
by Arran Frood / November 20, 2012
18. Reason: New Study Confirms MDMA’s Effectiveness in Psychotherapy | view
by Jacob Sullum / November 20, 2012
19. The Age: Dancing with Molly | view
by Eileen Ormsby / December 4, 2012
20. Care2: PTSD Sufferers See Long-Term Benefits From MDMA-Assisted Therapy | view
by Beth Buczynski / November 23, 2012
21. VIDEO: NBC San Diego: Scientists to Test Ecstasy for PTSD Vets | view
November 27, 2012
22. VIDEO: NBC Los Angeles: Party Drug May Help Tough Cases of PTSD | view
by Tony Shin and R. Stickney / November 27, 2012
23. VIDEO: Rick Doblin Talks About the Future of Psychedelics | view
November 28, 2012
24. PODCAST: Brad Burge Talks about MDMA and PTSD on Being Bipolar Podcast | listen
November 23, 2012
Explore MAPS in the Media for even more psychedelic and medical marijuana research news.
MORE NEWS
25. Veterans and the War on Drugs: New Report from the Drug Policy Alliance
Healing a Broken System: Veterans and the War on Drugs is a new report from the Drug Policy Alliance that examines the plight of returning veterans who struggle with incarceration and psychological wounds of war such as addiction and post-traumatic stress disorder—and suggests reforms that could improve the health and preserve the freedom of American soldiers returning from war zones and transitioning back to civilian life. This report recommends alternatives to incarceration for nonviolent drug offenses, increased access to overdose prevention programs and medication-assisted therapy, and research evaluating innovative treatment modalities such as medical marijuana and MDMA-assisted psychotherapy. View the issue brief.
26. Survey: Have You Had Experiences with Ibogaine?
The Ibogaine Experiences Research Group, a group of researchers not affiliated with MAPS, is interested in learning about your experience with ibogaine treatment. Researchers are conducting an online survey, which is completely anonymous, and invite anyone who has used ibogaine to participate. Researchers are based out of The School of Professional Psychology of Spalding University in Louisville, KY, USA. For more information, please click here.
27. Larry Hagman (1931-2012): LSD was “the most illuminating experience” of his life
Larry Hagman passed away on November 23, 2012, at the age 81. Larry was a famous Hollywood actor, known for his roles in Dallas and I Dream of Jeannie. He was a notable supporter of psychedelic research, as well as a generous contributor to MAPS. We thank Larry for his generosity, his support, his humor, and his friendship. Larry speaks with MAPS Founder Rick Doblin, The New York Times, and others about his personal experiences with psychedelics.